author-photo

Robert G. Wilcox

University of Nottingham
Queen's University

169

Papers

19953

Citations

Citation Trend

Filter By

Papers (169) Sort By

Journal Conference Others

β-Blockers, heart disease and COPD: current controversies and uncertainties

2017 Thorax
- Jillian G. Baker
- Robert G. Wilcox
Show All
- Source
- Cite
- Save
Citations (38)
Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial

2016 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (47)
The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control for attenuation of microvascular obstruction during primary percutaneous coronary intervention

2016
Show All
- Source
- Cite
- Save
Citations (8)
Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged

2015 Heart
Show All
- Source
- Cite
- Save
Citations (20)
Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?

2015 Journal of the American Heart Association
Show All
- Source
- Cite
- Save
Citations (9)
Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).

2014 American Journal of Cardiology
Show All
- Source
- Cite
- Save
Citations (25)
STEMI Patients Randomized to a Pharmaco-Invasive Strategy or Primary PCI: The STREAM 1-Year Mortality Follow-Up

2014 Circulation
Show All
- Source
- Cite
- Save
Citations (4)
PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease

2014 Journal of Thrombosis and Thrombolysis
Show All
- Source
- Cite
- Save
Citations (16)
The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial

2014 Trials
Show All
- Source
- Cite
- Save
Citations (13)
An analysis of TRITON-TIMI 38, based on the 12 month recommended length of therapy in the European label for prasugrel.

2014 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (6)